Abstract

IGF-I, Insulin like growth factor-I is a multi-functional polypeptide which organizes the proliferation and differentiation of various cell types and has a metabolic activity similar to insulin. We know that IGF-I receptors localize in the gastrointestinal tract. Polyamines play an important role in the gastrointestinal growth which connect with IGF-I. DFMO, I±-difluoromethylornithine is an irreversible inhibitor of ODC, ornithine decarboxylase, the rate-limiting enzyme in the synthesis of polyamines. In the IGF-I-promoted growth the role of polyamines mainly investigate in vitro systems, however, in vivo studies are necessary to clarify the subject. Our aim in this study is to examine the in vivo role of IGF-I as a stimulant in the growth of developing rat's small intestine, and to clarify the role of polyamines in the period of growth promoted by IGF-I. In this study, animals were divided into 2 groups. DFMO (500 mg/kg/day) was administered for 10 days to 9 rats forming the experimental group. Sterile 0.9% NaCl was injected at the same volume as for the experimental animals into 8 rats forming the control group. Tissue samples were taken from the rats for histological, immunohistochemical and biochemical analyses on the 10th day. In the group given DFMO, the expansion and compression of the villi, as well as a decrease in the PAS-positive reaction intensity of brush border and in the number of goblet cells were observed. mmunohistochemical assessments showed that the number of PCNA, ODC and IGF-I positive cells in the DFMO-treated group decreased significantly, compared with the control group. Biochemical investigations showed that DNA values in the small intestinal tissue decreased insignificantly in the DFMO treated group as compared to the control one. We concluded that application of DFMO in the developing rat small intestine inhibited polyamine synthesis and IGF-I synthesis and partially prevented growth of the intestine. Keywords: Polyamine, I±-difluoromethylornithine, insulin-like growth factor-I, ornithine decarboxylase

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.